Evox Therapeutics Closes £69.2M Series C Financing

20 Feb, 2021

Evox Therapeutics Closes £69.2M Series C Financing
Photo by Hack Capital on Unsplash

– Evox Therapeutics from Oxford closed $95.4m Series C funding.
– The round was led by Redmile Group with participation from new investors OrbiMed and Invus and existing investors Oxford Sciences Innovation (OSI), GV (formerly Google Ventures) and Cowen Healthcare Investments.
– The company intends to use the funds to advance its exosome-based therapeutics pipeline, including progression of several rare disease assets into the clinic, and continued development of its DeliverEXTM exosome drug platform.

Biotechnology Europe Health Care Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: